ResMed | RMD - 销售和管理费用

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 28.66B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	销售和管理费用	更改		日
Ansell	USD 274.8M		7.6M	2025-12
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 84.55M		6.21M	2026-03
Baxter International	USD 728M		33M	2026-03
Cochlear	AUD 449.4M		214.45M	2025-12
Cooper Companies	USD 676.2M		303.1M	2026-03
CSL	USD 1.23B		498M	2025-12
Dexcom	USD 349.7M		49.8M	2026-03
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Fisher Paykel Healthcare	NZD 285.5M		11.6M	2025-12
Globus Medical	USD 297.77M		20.7M	2026-03
Haemonetics	USD 109.15M		7.54M	2025-12
Idexx Laboratories	USD 299.85M		24.18M	2026-03
Inogen	USD 43.77M		510K	2024-06
Insulet	USD 317.2M		14.2M	2026-03
Integra LifeSciences	USD 178.24M		21.79M	2026-03
Intuitive Surgical	USD 613.3M		73.8M	2026-03
Medtronic	2.96B		9M	2025-12
Philips	EUR 1.18B		121M	2026-03
Ramsay Health Care	AUD 5.29B		3.2M	2024-12
ResMed	USD 279.8M		1.4M	2026-03
Sigma Healthcare	AUD 134.77M		9.73M	2024-12
Sonic Healthcare	AUD 2.52B		2.46B	2024-12
Steris	USD 351.8M		500K	2026-03
Teleflex	USD 226.01M		3.64M	2026-03
Thermo Fisher Scientific	USD 1.8B		179M	2026-03